Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:12-Aminododecanoic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004153 AN006894 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST002283 AN003728 The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains Bone Human University of Central Lancashire LC-MS
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST002016 AN003284 Metabolomics of COVID patients Blood Human COVID-19 University of Virginia LC-MS
ST001828 AN002965 Nested case–control study of environmental exposure within the ongoing Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) pregnancy cohort. Blood Human University of Michigan LC-MS
ST001527 AN002549 Lung cancer metabolomics analysis Tumor cells Human Cancer University of Louisville LC-MS
ST000551 AN000841 Investigating large scale metabolomics in mice tissue lacking insulin receptors and IGF-1 receptors Muscle Mouse Diabetes Mayo Clinic LC-MS
ST000551 AN000842 Investigating large scale metabolomics in mice tissue lacking insulin receptors and IGF-1 receptors Muscle Mouse Diabetes Mayo Clinic LC-MS
ST000422 AN000669 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic LC-MS
ST000421 AN000665 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic LC-MS
ST000221 AN000329 Normal plasma cells,Low proliferation multiple myeloma and High proliferation multiple myeloma cells Bone marrow Human Cancer Mayo Clinic LC-MS
ST000047 AN000080 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic LC-MS
ST000046 AN000076 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
ST000046 AN000077 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
  logo